Nanosonics | NAN - Ebitda

Stock Price
3.63
Daily Change
-0.12 -3.20%
Monthly
1.68%
Yearly
-22.93%
Q2 Forecast
3.62

Nanosonics reported AUD12.49M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Alcidion AUD 4.19M 365K Dec/2025
Ansell USD 185.8M 7M Dec/2025
Avita Medical AUD -9.69M 12.21M Dec/2025
Cochlear AUD 306.4M 13.5M Dec/2025
CSL USD 3.13B 1.17B Dec/2025
Fisher & Paykel Healthcare NZD 364M 78.5M Jun/2025
Healius AUD 74.9M 40.3M Jun/2025
Integral Diagnostics AUD 46.27M 3.52M Jun/2024
Mayne Pharma AUD 20.9M 5.2M Jun/2025
Polynovo AUD 3.89M 100K Dec/2025
Pro Medicus AUD 97.25M 8.99M Dec/2025
Ramsay Health Care AUD 1.12B 10.6M Dec/2025
ResMed USD 547.48M 27.46M Dec/2025
Somnomed AUD 764.45K 479.23K Jun/2023
Sonic Healthcare AUD 839.07M 51.09M Dec/2024